ArticleHepatology (Baltimore, Md.)2025

Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk.

Paula Olaizola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.